Skip navigation | ||
|
||
Medical Encyclopedia |
|
Other encyclopedia topics: | A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9 |
Contents of this page: | |
Alternative names
Arteriovenous malformation - pulmonaryDefinition Return to top
This condition is an abnormal passageway (fistula) between an artery and vein that occurs in the blood vessels of the lungs. The result is a shunting of blood, and thus the blood is not oxygenated properly.Causes, incidence, and risk factors Return to top
Pulmonary arteriovenous fistulas are congenital malformations (present at birth) that result when the blood vessels of the lung do not develop normally.
Patients with Rendu-Osler-Weber disease (ROWD), also called hereditary hemorrhagic telangiectasis (HHT), frequently have abnormal blood vessel development at many sites in the body, including the lungs, brain, nasal passages, liver, and gastrointestinal organs. This condition is slightly more common in women than in men.
Symptoms Return to top
Many patients have no symptoms. Some patients have difficulty breathing, shortness of breath with exertion, difficulty exercising, or bloody sputum. Nosebleeds may occur in patients with HHT.
Other symptoms that may occur include blue skin (cyanosis), clubbing of the fingers (enlargement of the tips of the fingers), and a murmur heard with a stethoscope placed over the malformation.
Signs and tests Return to top
Treatment Return to top
A small number of patients who have no symptoms may need no specific treatment. For most patients with either single or multiple fistulas, the treatment of choice is surgery to remove the abnormal vessels and the adjacent lung tissue.
For some patients, it may be possible to block the fistula at the time of arteriogram.
Expectations (prognosis) Return to top
The outlook for patients with HHT is less favorable than for those without HHT. The result of surgery to remove the abnormal vessels is usually good, and recurrence is unlikely.
Recurrence is possible if the treatment is to block the fistula (embolization).
Complications Return to top
The most worrisome complication for patients with untreated pulmonary arteriovenous fistulas is "paradoxical embolism" -- where a blood clot travels from the lungs to the arms, legs, or brain (if it travels to the brain, it can produce a stroke). Major complications after treatment for this condition are unusual.
Calling your health care provider Return to top
Patients with frequent nosebleeds or difficulty breathing, especially if there is also a history of HHT, should consult their physician.
Prevention Return to top
Because this condition is congenital (present at birth), prevention is not usually possible.
Update Date: 2/6/2003 Updated by: David A. Kaufman, M.D., Pulmonary & Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.
Home | Health Topics | Drug Information | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Copyright | Privacy | Accessibility | Selection Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 28 October 2004 |